Floris Alexander van de Laar

Summary

Affiliation: Radboud University Nijmegen Medical Centre
Country: The Netherlands

Publications

  1. ncbi request reprint alpha-Glucosidases
    V V Krasikov
    Konstantinov St. Petersburg Nuclear Physics Institute, Gatchina, Leningrad Region, 188350, Russia
    Biochemistry (Mosc) 66:267-81. 2001
  2. ncbi request reprint Is acarbose equivalent to tolbutamide as first treatment for newly diagnosed type 2 diabetes in general practice? A randomised controlled trial
    Floris A van de Laar
    Department of General Practice, University Medical Centre Nijmegen, 229 HAG, P O Box 9101, 6500 HB, Nijmegen, The Netherlands
    Diabetes Res Clin Pract 63:57-65. 2004
  3. pmc Fat intake in patients newly diagnosed with type 2 diabetes: a 4-year follow-up study in general practice
    Floris A van de Laar
    Universtiy Medical Centre Nijmegen, Department of General Practice, Nijmegen, The Netherlands
    Br J Gen Pract 54:177-82. 2004
  4. ncbi request reprint Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis
    Floris A van de Laar
    Department of General Practice, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    Diabetes Care 28:154-63. 2005
  5. ncbi request reprint Eating behaviour and adherence to diet in patients with Type 2 diabetes mellitus
    F A van de Laar
    Radboud University Nijmegen Medical Center, Department of General Practice, Nijmegen, The Netherlands
    Diabet Med 23:788-94. 2006
  6. ncbi request reprint Limited evidence for effects of diet for type 2 diabetes from systematic reviews
    F A van de Laar
    Department of General Practice, Radboud University Nijmegen Medical Centre, 6500 HB Nijmegen, The Netherlands
    Eur J Clin Nutr 61:929-37. 2007
  7. doi request reprint Prevalence of zebras in general practice: data from the Continuous Morbidity Registration Nijmegen
    Floris A van de Laar
    Department of General Practice, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    Eur J Gen Pract 14:44-6. 2008
  8. pmc Alpha-glucosidase inhibitors in the early treatment of type 2 diabetes
    Floris Alexander van de Laar
    Radboud University Nijmegen Medical Centre, Department of General Practice, Nijmegen, The Netherlands
    Vasc Health Risk Manag 4:1189-95. 2008

Collaborators

Detail Information

Publications8

  1. ncbi request reprint alpha-Glucosidases
    V V Krasikov
    Konstantinov St. Petersburg Nuclear Physics Institute, Gatchina, Leningrad Region, 188350, Russia
    Biochemistry (Mosc) 66:267-81. 2001
    ..Experimental data on the elucidation of amino acid residues essential for catalysis are also discussed...
  2. ncbi request reprint Is acarbose equivalent to tolbutamide as first treatment for newly diagnosed type 2 diabetes in general practice? A randomised controlled trial
    Floris A van de Laar
    Department of General Practice, University Medical Centre Nijmegen, 229 HAG, P O Box 9101, 6500 HB, Nijmegen, The Netherlands
    Diabetes Res Clin Pract 63:57-65. 2004
    ..We conclude that the results of this study favour tolbutamide over acarbose as first treatment for patients with newly diagnosed type 2 diabetes...
  3. pmc Fat intake in patients newly diagnosed with type 2 diabetes: a 4-year follow-up study in general practice
    Floris A van de Laar
    Universtiy Medical Centre Nijmegen, Department of General Practice, Nijmegen, The Netherlands
    Br J Gen Pract 54:177-82. 2004
    ....
  4. ncbi request reprint Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis
    Floris A van de Laar
    Department of General Practice, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    Diabetes Care 28:154-63. 2005
    ..To review the effects of monotherapy with alpha-glucosidase inhibitors (AGIs) for patients with type 2 diabetes, with respect to mortality, morbidity, glycemic control, insulin levels, plasma lipids, body weight, and side effects...
  5. ncbi request reprint Eating behaviour and adherence to diet in patients with Type 2 diabetes mellitus
    F A van de Laar
    Radboud University Nijmegen Medical Center, Department of General Practice, Nijmegen, The Netherlands
    Diabet Med 23:788-94. 2006
    ..To assess restrained, emotional and external eating behaviour in patients newly diagnosed with Type 2 diabetes compared with the general population, and to assess the relationship of eating behaviour to changes in fat and energy...
  6. ncbi request reprint Limited evidence for effects of diet for type 2 diabetes from systematic reviews
    F A van de Laar
    Department of General Practice, Radboud University Nijmegen Medical Centre, 6500 HB Nijmegen, The Netherlands
    Eur J Clin Nutr 61:929-37. 2007
    ..We assessed the results, quality and external validity of systematic reviews on diet in patients with type 2 diabetes...
  7. doi request reprint Prevalence of zebras in general practice: data from the Continuous Morbidity Registration Nijmegen
    Floris A van de Laar
    Department of General Practice, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    Eur J Gen Pract 14:44-6. 2008
    ..To explore the prevalence of rare diseases in the Continuous Morbidity Registration (CMR) Nijmegen, and to discuss methodological difficulties in the study of rare diseases in general practice...
  8. pmc Alpha-glucosidase inhibitors in the early treatment of type 2 diabetes
    Floris Alexander van de Laar
    Radboud University Nijmegen Medical Centre, Department of General Practice, Nijmegen, The Netherlands
    Vasc Health Risk Manag 4:1189-95. 2008
    ..For patient with impaired glucose tolerance AGIs may prevent, delay or mask the occurrence of type 2 diabetes. A possible beneficial effect on cardiovascular events should be confirmed in new studies...